Repair of damage to the central nervous system (CNS) is inhibited by the presence of myelin proteins that prevent axonal regrowth. Consequently, growth inhibitors and their common receptor have been identified as targets in the treatment of injury to the CNS. Here we describe the structure of the extracellular domain of the neurite outgrowth inhibitor (Nogo) in a membrane-like environment. Isoforms of Nogo are expressed with a common C terminus containing two transmembrane (TM) helices. The ectodomain between the two TM helices, Nogo-66, is active in preventing axonal growth [GrandPre T, Nakamura F, Vartanian T, Strittmatter SM (2000) Nature 403:439-444]. We studied the structure of Nogo-66 alone and in the presence of 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) vesicles and dodecylphosphocholine (DPC) micelles as membrane mimetics. We find that Nogo-66 is largely disordered when free in solution. However, when bound to a phosphocholine surface Nogo-66 adopts a unique, stable fold, even in the absence of TM anchors. Using paramagnetic probes and protein-DPC nuclear Overhauser effects (NOEs), we define portions of the growth inhibitor likely to be accessible on the cell surface. With these data we predict that residues (28-58) are available to bind the Nogo receptor, which is entirely consistent with functional assays. Moreover, the conformations and relative positions of side chains recognized by the receptor are now defined and provide a foundation for antagonist design.
D
amage to the adult central nervous system (CNS) caused by stroke, spinal cord injury, and neurodegenerative conditions is often devastating because axons are unable to regenerate. Axonal regrowth does occur within the peripheral nervous system (PNS). Interestingly, CNS neurons will grow when grafted to PNS tissue, demonstrating that it is the environment, not the neuron, that is refractory toward repair within the CNS (1, 2) . CNS oligodendricites produce myelin, an insulating sheath surrounding the axon. Growth inhibitory activity is associated with several myelin membrane proteins including Nogo (3) (4) (5) (6) (7) (8) (9) . Nogo-66 is the extracellular domain common to human isoforms Nogo-A, -B and -C. The Nogo-66 fragment is flanked by two transmembrane helices in the native protein that anchor the protein at the oligodendrocyte cell membrane. Inhibition of axonal growth is mediated through binding to the Nogo receptor (NgR) on the axon. Within Nogo-66, a truncated peptide corresponding to residues 31-55 shows the strongest ability to collapse neuronal growth (8) . Thus Nogo residues that bind the receptor are likely to occur within that fragment. Another fragment corresponding to the first 40 residues of Nogo-66 has been reported to act as an antagonist (10) , presumably binding the receptor but failing to transmit the stop growth signal (although the activity level of that peptide has not been confirmed) (11) . Nogo, NgR, and other NgR ligands have been identified as targets toward therapeutic repair of CNS damage.
Nogo exists in both plasma and endoplasmic reticulum (ER) membranes. Its activity as a growth inhibitor was discovered after it had already been identified as a reticulon protein (RTN-4) . Recently, Nogo (RTN-4) was proven to play a role in stabilizing the curvature of tubular ER (12) . Thus Nogo performs two very distinct functions: as an intracellular signalling molecule by binding the NgR or as a scaffolding protein in defining membrane architecture. Understanding these mechanisms depends on knowing the structure of the protein and its relative position within the membrane.
Here we report that the NMR structure of Nogo-66 in dodecylphosphocholine (DPC) micelles is a compact helical bundle. The structure was determined in two phases: 1) a low resolution structure was first defined based on a partial list of short-range NOEs; 2) this structure was then used to design attachment points for nitroxide spin labels as probes in measuring long-range paramagnetic relaxation enhancements (PREs). Orienting the protein at the phosphocholine surface is essential in understanding its function as an inhibitor. Using four accessibility measurements, we predict surface residues available to bind the receptor.
Results and Discussion
Because Nogo-66 is biologically active (8), we chose to study the structure of this small domain alone. In an aqueous environment, we find that Nogo-66 is largely disordered based on the following data. The CD spectrum of aqueous Nogo-66 indicates very little secondary structure (Fig. 1A , Red Trace). Applying deconvolution methods (13), we estimate secondary structure content as 10% helix, 30% beta-strand, 20% turn, and 40% disordered. We determined that the small amount of secondary structure evident in the CD spectrum is transient and not involved in a stable fold based on the following NMR data. The NMR spectra of 15 N, 13 C-labeled Nogo-66 was fully assigned in an aqueous environment. Nogo-66 chemical shifts are similar to those of random coil residues (Fig. S1 ). In addition, many backbone 1 J CαN -couplings are 6-8 Hz, predicting dihedral phi angles in the random coil range. All of the backbone amide protons exchange immediately upon transfer to D 2 O, indicating that aqueous Nogo-66 lacks stable secondary structure. Finally, upon analysis of NOESY spectra, we find no medium-or long-range distance constraints (Fig. S1) . Thus, the limited secondary structure present in aqueous Nogo-66 is dynamic, and we find no evidence of tertiary structure. Although this domain is active, we find it to be highly flexible in an aqueous environment. Notably, other studies have found that most regions are disordered in the largest splicevariant, Nogo-A (1,192 amino acids) (14, 15) . Disordered structure is an interesting parallel feature between Nogo and another This article is a PNAS Direct Submission. 1 To whom correspondence should be addressed. E-mail: mcocco@uci.edu.
This article contains supporting information online at www.pnas.org/cgi/content/full/ 0911817107/DCSupplemental. important CNS protein, myelin basic protein (MBP), that becomes helical at the myelin membrane surface (reviewed in ref. 16) . Given that protein biological activity most often requires a folded, stable structure, we hypothesize that Nogo-66 adopts a defined structure when bound to the Nogo receptor in activity assays. The conformation of Nogo on the cell membrane may likely be similar to the receptor bound form to promote recognition.
Nogo-66 was first constructed for activity assays by removal of flanking segments expected to be TM helices (8) . In many cases a TM helix can be removed to yield an active autonomous proteinfolding unit. Although deletion of TM helices should be sufficient to release the protein domain from the 30-Å acyl-chain region of the membrane, there is an additional 15-Å headgroup region that must be traversed for the protein to be fully exposed (17) . Based on the lack of structure we found in Nogo-66, we hypothesized that the headgroup region of the membrane surface may play a role in defining the structure of this extracellular domain. To determine the structural influence of phosphocholine (PC) on the fold of Nogo-66, we prepared DMPC lipid vesicles and collected CD data (Fig. 1A , Black Trace). Notably, Nogo-66 becomes significantly ordered in the presence of lipid vesicles, calculated to be 88% helix. Thus, lipid drives folding of Nogo-66 and dramatically increases the helical content. To determine the affinity of Nogo-66 for lipid, we titrated DMPC vesicles into a solution of Nogo-66 and monitored ellipticity at 222 nm. Nogo-66 binds DMPC with a moderate partition coefficient
5 . Thus, Nogo-66 interacts relatively strongly with lipid even in the absence of TM helices. Because lipid vesicles are unsuitable for liquid-state NMR, we also assessed several detergent micelles and detergent/lipid bicelles for their ability to maintain the helicity induced by lipid vesicles. We found that DPC micelles maintain the secondary structure (Fig. 1A , Blue Trace) and provide an excellent environment for NMR studies (Fig. 1B) . Using NMR diffusion measurements we find Nogo-66 is fully bound to DPC at the concentrations used in our NMR experiments. 15 N, 13 C-labeled Nogo-66 was used to assign the NMR spectra of the protein in DPC using standard triple-resonance NMR experiments. An initial family of NMR structures with an RMSD of 3.5 Å was generated with a constraint list of ∼500 NOEs. This preliminary structure and specific contacts found between protein and DPC guided us to engineer cysteine residues into the sequence at two positions, 31 and 42, unlikely to affect the structure or DPC binding. These two cysteines were placed independently at turns between helices two/three and three/four (Fig. 1D ). Nitroxide labels (MTSL) were covalently attached to generate long-range distance constraints based on PREs. The NMR peak positions of residues in the MTSL-labeled samples were very similar to those of unlabeled wild-type with the exception of the labeled position. MTSL samples provided an additional 18 PRE restraints that were particularly useful in defining the long loop between the first and second helices. These and the full set of NOEs and J-couplings were used for the final refinement providing a family of structures with a backbone RMSD of 1.6 Å ( Table 1 and Table S1 and Fig. 1 C and D and Figs. S2 and S3A ). The structure of Nogo-66 induced by DPC is a compact helical bundle consisting of five helices wrapping upon each other. Thirty-two of the 66 backbone amide hydrogens exchange slowly over a period of hours to days (Fig. S3B) , indicating that Nogo-66 forms a stable fold on the DPC surface. Amide positions protected from exchange are distributed throughout the molecule including the ends, consistent with the N and C termini being well constrained by NOEs. We also analyzed NOE data of Nogo-66 in fast-tumbling DMPC/ DHPC bicelles. Although the peaks are broader, we find that the structural features defined in DPC are maintained in the presence of disks containing DMPC bilayers.
The most meaningful interpretation of the Nogo-66 structure can only be made if the residues accessible to bind the receptor at the cell surface are defined. Our strategy to position Nogo-66 in the membrane includes analysis of both protein/DPC NOEs and signal broadening induced by paramagnetic reagents shown in Fig. 2 . Gadiodiamide is a common MRI agent restricted to the aqueous environment; signals of residues that are broadened by chelated Gd 3þ are colored blue in Fig. 2 (19) (representative data provided in Fig. S4 ). Mn 2þ is also soluble in the aqueous phase but is small enough to partition to the phosphate region of the lipid headgroups (20) and broadens the set of protein signals from residues exposed to water and in contact with PC headgroups. A nitroxide-labeled lipid was used to probe the portion of Nogo-66 imbedded in DPC (21) . In addition to these signal-broadening effects, we found specific contacts between DPC and Nogo-66 in the course of NOE analysis (for example Fig. S5 ). Contacts to either the aqueous phase or DPC/lipid in are catalogued Table S2 . There is some overlap in positions influenced by both lipid/DPC and solvent accessible probes. This is likely a consequence of dynamics; the flexible DPC and lipid acyl chains can "snorkel" up to contact groups in and above the headgroup region, and the protein has mobility within the micelle. Regardless, there is a consensus of residues exposed to either solvent or doxyl/DPC, and these data allow us to orient the protein on the surface of a membrane bilayer in a manner that optimizes lipid or solvent contacts, shown in Fig. 3A .
Integral membrane proteins can be identified reasonably well through hydropathy analysis (22) , but there is no signature sequence or motif that can clearly identify a peripherally associated membrane protein. Consequently, we do not know how many proteins targeted for structural analysis that have been found to be disordered may actually require a lipid surface to fold Fig. 2 . Solvent or lipid/DPC accessibility is defined using paramagnetic reagents and NOEs. Solvent accessibility of Nogo-66 in DPC was probed using paramagnetic manganese and gadolinium. Mn þ2 broadens signals of residues exposed to the solvent as well as those interacting within the head group region, whereas the compound gadodiamide will affect only those residues exposed to the solvent. Similarly, residues in contact with the paramagnetic lipid, 1-palmitoyl-2-stearoyl-(7-doxyl)-sn-glycero-3-phosphocholine are broadened by the 7-doxyl. The schematic (Left) demonstrates regions of accessibility of the various paramagnetic reagents including a few DPC molecules. In addition, protein groups interacting with DPC were identified by comparing 13 C-edited NOESYHSQC spectra of Nogo-66 in presence of d-DPC to Nogo-66 in h-DPC. Spectra in h-DPC contained additional NOE peaks arising from specific protein-lipid interactions (Fig. S5) . Residues affected by paramagnetic agents are shown on the structure of Nogo-66. Top panels depict affects of gadodiamide (Left) and Mn þ2 (Right). Bottom panels depict residues broadened by 7-doxyl (Left) and residues interacting with DPC based on NOEs (Right). properly. We show here that the extracellular domain, Nogo-66, requires a PC surface to adopt a compact helical fold. Several peptides and proteins are known to form extended helices on a PC surfaces, e.g., Jao et al. (23) . However, Nogo-66 is unique in that it contains extensive tertiary contacts with five helices folding onto each other. The structure sequesters some hydrophobic amino acids within the hydrophobic protein core and exposes other hydrophobic side chains to the hydrophobic DPC ( Fig. 3 B and C) . Forces that distinguish hydrophobic protein-protein from hydrophobic protein-lipid interactions define membrane protein structures but are not well understood. Nogo-66 displays both kinds of hydrophobic contacts. It has been demonstrated that aromatic groups will partition favorably into PC headgroup regions (17) . In the case of Nogo-66, aromatic rings are exposed within the headgroup region of DPC, indicating that although they contribute to protein-lipid interactions, they have a limited role in defining the internal protein architecture. Interestingly, the single protein structure within the Protein Data Bank that matches the Nogo-66 fold contains only three identical residues [comparison to 1i2t.pdb (24), Fig. S6] . Thus, the sequence of Nogo could not have been used to predict this structure based on our current knowledge of protein structures.
Our structure provides insight into Nogo functional assays and receptor binding (modeled in Fig. 4) . Using peptide fragments, the Strittmatter lab found that residues 31-55 are most active in preventing axonal growth (8) . Within that peptide, residues 50-54 were found to be essential for inhibiting neurite outgrowth (25) . In Fig. 4 , residues 31-55 are highlighted in our structure of Nogo-66. We find this segment of the protein to be the most accessible for receptor binding. The first 40 residues of Nogo-66 has activity as an antagonist (10) . Most of the first 40 residues are inaccessible in our structure of Nogo-66; of that fragment, only residues 28-40 of the putative antagonist are accessible as a helix-turn-helix. If the antagonist activity of Nogo-40 is defined by solvent accessible groups, a smaller fragment based on the structure of residues 28-40 may be all that is needed to stimulate axonal repair.
Materials and Methods
Nogo-66 constructs and its two variants were incorporated into the vector pKKT7-H as N-terminal His 6 tag (MHHHHHHLVPRGM) protein. The sequence of Nogo-66 (beginning at position 1054 within the Nogo-A sequence), RIYKG-VIQAIQKSDEGHPFRAYLESEVAISEELVQKYSNSALGHVNSTIKELRRLFLVDDLVD-SLK, and the site-directed mutagenesis products were confirmed by DNA sequencing. All constructs were over expressed in Escherichia coli BL21 (DE3) (Stratagene) and isotope-labeled by expressing in minimal media supplemented with 15 NH 4 Cl and 13 C-labeled D-glucose (details in SI Text). Protein was isolated using Ni-NTA affinity chromatography under denaturing conditions. MALDI-TOF showed the purified protein to be the correct molecular weight. CD and NMR experiments are described in supplementary information. Sequential assignment of residues was carried out using ANALYSIS (26) . To determine the orientation of Nogo-66 on the DPC surface, accessibility was deduced from broadening of DQFCOSY signals wherein 5 mM manganese and 8 mM gadodiamide (gadolinium(III) 5,8-bis(carboxylatomethyl)-2-[2-(methylamino)-2-oxoethyl]-10-oxo-2,5,8,11-tetraazadodecane-1-carboxylate hydrate) were used to probe residues exposed to aqueous environment and 2 mM 1-palmitoyl-2-stearoyl-(7-doxyl)-snglycero-3-phosphocholine were used to identify residues embedded in DPC. Additional information defining protein-DPC contacts was derived by comparing 13 C-edited NOESYHSQC spectra of Nogo-66 in presence of 100 mM d-DPC to those in 100 mM h-DPC. Residues that interact with h-DPC were found to have additional NOE peaks corresponding to DPC resonances. Structure calculations were carried out using the ab initio simulated annealing protocol of Xplor-NIH program, version 2.2 (27, 28) .
Distance restraints were derived from the NOE cross peaks; dihedral angle constraints were derived from TALOS (29) . PRE data were incorporated as distance constraints during the refinement step. Protein structures were analyzed using PROCHECK (30, 31) and displayed using Chimera (32) . The coordinates representing the structure of Nogo in DPC and the experimental restraints have been submitted to the PDB with access code 2ko2.
Full methods and any associated references are available in SI Text.
